Outcome of Patients with ALK plus NSCLC and Brain Metastases in Relation to Disease Burden and Clinical Management

被引：0
|
作者：
De Petris, Luigi [1 ]
Friesland, Signe [1 ]
Brodin, Daniel [2 ]
Carstens, Hanna [1 ]
Falkenius, Johan [1 ]
Grundberg, Oscar [2 ]
Lofdahl, Magnus [2 ]
Helleday, Clara Lenneby [1 ]
Karimi, Reza [2 ]
Ojdahl-Boden, Anna [2 ]
Tsakonas, Georgios [1 ]
Ekman, Simon [1 ]
Kolbeck, Karl-Gustav [2 ]
机构：
[1] Karolinska Univ Hosp, Oncol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Resp Med & Allergol, Stockholm, Sweden
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
ALK; WBRT; CNS Metastasis; 2nd generation ALKi;
D O I：
10.1016/j.jtho.2016.11.1294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03b-013
引用
收藏
页码：S940 / S941
页数：2
相关论文
共 50 条
  • [1] SYMPTOMATIC AND ECONOMIC BURDEN OF BRAIN METASTASES IN PATIENTS WITH ALK plus NSCLC
    Macalalad, Alexander
    Sasane, Medha
    Zhang, Jie
    Culver, Kenneth
    Dea, Katherine
    Nitulescu, Roy
    Wu, Eric
    Guerin, Annie
    NEURO-ONCOLOGY, 2014, 16
  • [2] Comparison of clinical and MRI features of brain metastases between ALK plus and ALK- NSCLC
    Ren, Xiaolu
    Zhang, Xuting
    Lei, Xiaoyan
    Ma, Weiqin
    Zhang, Ting
    Wang, Yuxiang
    Ren, Jiwei
    CANCER MEDICINE, 2024, 13 (11):
  • [3] ALK-Translocation and Brain Metastases: A Retrospective Study. Correlation Between Clinical Outcome, Disease Burden and Management
    Grundberg, O.
    Friesland, S.
    Abdel-Halim, S.
    Gagatek, S.
    Karimi, R.
    Ojdahl-Boden, A.
    Tsakonas, G.
    Bradic-Lindh, M.
    Kolbeck, K.
    Wagenius, G.
    Ekman, S.
    Lindberg, K.
    De Petris, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S798 - S799
  • [4] Symptoms and QOL with Ceritinib in ALK plus NSCLC Patients with/without Brain Metastases
    Crino, Lucio
    Ahn, Myung-Ju
    De Marinis, Filippo
    Groen, H. J. M.
    Wakelee, Heather A.
    Hida, Toyoaki
    Mok, Tony
    Shaw, Alice
    Felip, Enriqueta
    Nishio, Makoto
    Scagliotti, Giorgio V. V.
    Branle, Fabrice
    Emeremni, Chetachi
    Sutradhar, Santosh
    Quadrigli, Massimiliano
    Zhang, Jie
    Spigel, David
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S379 - S379
  • [5] Economic Burden and Treatments of Progression to Metastatic Disease in ALK plus NSCLC Patients
    Guerin, A.
    Sasane, M.
    Zhang, J.
    Culver, K.
    Macalalad, A.
    Nitulescu, R.
    Wu, E.
    Dea, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S44 - S45
  • [6] Treatment Patterns and Economic Burden of Brain Metastases (BM) in Patients with ALK plus mNSCLC Receiving ALK TKIs
    Le, H.
    Benjumea, D.
    Li, B.
    Shao, A.
    Rava, A.
    Silver, M.
    Vaghela, S.
    Thomaidou, D.
    Lin, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S674 - S674
  • [7] PROs with Ceritinib in ALKi-Naive ALK plus NSCLC Patients with and without Brain Metastases
    Park, Keunchil
    Felip, Enriqueta
    Orlov, Sergey
    Yu, Chong-Jen
    Tsai, Chun-Ming
    Nishio, Makoto
    Dols, Manuel Cobo
    Mckeage, Mark
    Su, Wu-Chou
    Mok, Tony
    Scagliotti, Giorgio V. V.
    Spigel, David R.
    Zhang, Jie
    Branle, Fabrice
    Emeremni, Chetachi
    Sutradhar, Santosh
    Quadrigli, Massimiliano
    Shaw, Alice
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S379 - S380
  • [8] Brigatinib Activity in Patients with ALK plus NSCLC and Intracranial CNS Metastases in Two Clinical Trials
    Gettinger, Scott
    Kim, Dong-Wan
    Tiseo, Marcello
    Langer, Corey
    Ahn, Myung-Ju
    Shaw, Alice
    Huber, Rudolf
    Hochmair, Maximilian
    Kim, Sang-We
    Bazhenova, Lyudmila
    Gold, Kathryn
    Ou, Sai-Hong
    West, Howard
    Reichmann, William
    Haney, Jeff
    Clackson, Tim
    Haluska, Frank
    Kerstein, David
    Camidge, D. Ross
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S273 - S274
  • [9] Cost Analysis of the Management of CNS Metastases in Patients with Advanced ALK plus NSCLC: Alectinib vs Crizotinib
    Massuti, B.
    Lazaro, M.
    Isla, D.
    Gordo, R.
    Ruiz De Alda, L.
    Ortega, N.
    Oyaguez, I.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S856 - S856
  • [10] Clinical experience with crizotinib in patients (pts) with advanced ALK plus non-small cell lung cancer (NSCLC) and brain metastases
    Crino, L.
    Ahn, M. J.
    Ou, S. H. I.
    Solomon, B. J.
    Costa, D. B.
    Shreeve, S. M.
    Wiltshire, R.
    Selaru, P.
    Zhou, C.
    Riely, G. J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S800 - S800
12345